NEW YORK (GenomeWeb News) – As part of a new push to become a leading player in synthetic biology, the UK has provided £5.3 million ($8 million) to fund 15 new synthetic biology technology development projects at a number of companies.

The funding will fuel an array of tech development efforts at about a dozen companies. The grant winners were chosen through a competition for projects that will be led by businesses seeking to demonstrate the feasibility of using synthetic biology to create new products and processes or improve older ones.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.